Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 4330 | 48.24 |
09:36 ET | 400 | 48.12 |
09:39 ET | 100 | 47.97 |
09:41 ET | 1300 | 47.66 |
09:43 ET | 129 | 47.5579 |
09:45 ET | 374 | 47.74 |
09:52 ET | 100 | 47.815 |
09:54 ET | 1806 | 47.67 |
09:56 ET | 406 | 47.44 |
09:57 ET | 100 | 47.44 |
09:59 ET | 1356 | 47.25 |
10:01 ET | 400 | 47.105 |
10:06 ET | 1200 | 46.99 |
10:08 ET | 1415 | 47.045 |
10:10 ET | 545 | 47.2 |
10:12 ET | 100 | 47.185 |
10:14 ET | 200 | 47.195 |
10:15 ET | 200 | 47.215 |
10:17 ET | 800 | 47.31 |
10:21 ET | 476 | 47.3 |
10:24 ET | 2400 | 47.34 |
10:26 ET | 5899 | 47.395 |
10:28 ET | 6735 | 47.44 |
10:30 ET | 2600 | 47.52 |
10:32 ET | 1981 | 47.43 |
10:33 ET | 1174 | 47.505 |
10:35 ET | 3119 | 47.645 |
10:37 ET | 1000 | 47.625 |
10:39 ET | 1000 | 47.485 |
10:42 ET | 2066 | 47.455 |
10:44 ET | 600 | 47.475 |
10:46 ET | 500 | 47.585 |
10:48 ET | 100 | 47.585 |
10:50 ET | 374 | 47.59 |
10:53 ET | 800 | 47.51 |
10:55 ET | 3132 | 47.43 |
10:57 ET | 136 | 47.42 |
11:00 ET | 400 | 47.48 |
11:02 ET | 3093 | 47.46 |
11:04 ET | 8900 | 47.35 |
11:08 ET | 1378 | 47.35 |
11:09 ET | 1400 | 47.45 |
11:11 ET | 100 | 47.4 |
11:13 ET | 900 | 47.43 |
11:15 ET | 983 | 47.58 |
11:18 ET | 325 | 47.52 |
11:20 ET | 689 | 47.545 |
11:22 ET | 2015 | 47.475 |
11:24 ET | 100 | 47.405 |
11:27 ET | 490 | 47.47 |
11:29 ET | 2600 | 47.45 |
11:31 ET | 800 | 47.46 |
11:33 ET | 1100 | 47.48 |
11:36 ET | 400 | 47.41 |
11:38 ET | 1800 | 47.31 |
11:40 ET | 696 | 47.37 |
11:42 ET | 100 | 47.355 |
11:44 ET | 100 | 47.355 |
11:45 ET | 1400 | 47.31 |
11:47 ET | 16084 | 47.15 |
11:49 ET | 728 | 47.035 |
11:51 ET | 1260 | 47.085 |
11:56 ET | 500 | 47.04 |
11:58 ET | 200 | 47.04 |
12:00 ET | 400 | 47.055 |
12:02 ET | 6446 | 47.18 |
12:03 ET | 876 | 47.14 |
12:05 ET | 2700 | 47.03 |
12:07 ET | 9379 | 47.21 |
12:09 ET | 1249 | 47.17 |
12:14 ET | 2312 | 47.37 |
12:16 ET | 7076 | 47.37 |
12:18 ET | 3120 | 47.31 |
12:20 ET | 3854 | 47.35 |
12:21 ET | 5477 | 47.34 |
12:23 ET | 1650 | 47.405 |
12:25 ET | 13388 | 47.6892 |
12:27 ET | 6185 | 47.6788 |
12:30 ET | 4900 | 47.4933 |
12:32 ET | 12313 | 47.395 |
12:34 ET | 5608 | 47.3 |
12:36 ET | 20906 | 47.15 |
12:38 ET | 703 | 47.36 |
12:39 ET | 1100 | 47.37 |
12:41 ET | 2500 | 47.33 |
12:43 ET | 500 | 47.31 |
12:45 ET | 2456 | 47.315 |
12:48 ET | 5900 | 47.485 |
12:50 ET | 1000 | 47.5 |
12:52 ET | 2570 | 47.525 |
12:54 ET | 700 | 47.56 |
12:56 ET | 1346 | 47.57 |
12:57 ET | 6105 | 47.4699 |
12:59 ET | 290 | 47.405 |
01:01 ET | 1300 | 47.33 |
01:03 ET | 1149 | 47.235 |
01:10 ET | 1405 | 47.275 |
01:12 ET | 100 | 47.32 |
01:15 ET | 1100 | 47.31 |
01:17 ET | 100 | 47.32 |
01:19 ET | 200 | 47.32 |
01:21 ET | 1500 | 47.21 |
01:24 ET | 1954 | 47.125 |
01:26 ET | 100 | 47.125 |
01:28 ET | 736 | 47.13 |
01:30 ET | 101 | 47.135 |
01:32 ET | 1701 | 47.1 |
01:33 ET | 1663 | 47.16 |
01:42 ET | 4230 | 47.2108 |
01:44 ET | 777 | 47.21 |
01:46 ET | 100 | 47.165 |
01:48 ET | 2865 | 47.125 |
01:50 ET | 100 | 47.125 |
01:51 ET | 3191 | 46.98 |
01:53 ET | 1953 | 46.86 |
01:55 ET | 700 | 46.795 |
02:00 ET | 400 | 46.77 |
02:02 ET | 1000 | 46.645 |
02:04 ET | 950 | 46.53 |
02:06 ET | 500 | 46.585 |
02:08 ET | 4420 | 46.7925 |
02:13 ET | 4346 | 46.745 |
02:15 ET | 800 | 46.805 |
02:18 ET | 1500 | 46.85 |
02:20 ET | 100 | 46.8 |
02:22 ET | 3779 | 46.73 |
02:24 ET | 1901 | 46.63 |
02:26 ET | 2020 | 46.59 |
02:27 ET | 100 | 46.58 |
02:29 ET | 2524 | 46.66 |
02:31 ET | 2945 | 46.5 |
02:33 ET | 410 | 46.5 |
02:36 ET | 1300 | 46.52 |
02:38 ET | 200 | 46.52 |
02:40 ET | 1320 | 46.515 |
02:42 ET | 1636 | 46.51 |
02:44 ET | 2600 | 46.58 |
02:47 ET | 4599 | 46.495 |
02:49 ET | 300 | 46.5 |
02:51 ET | 100 | 46.5 |
02:54 ET | 400 | 46.5 |
02:56 ET | 3107 | 46.695 |
02:58 ET | 1600 | 46.64 |
03:00 ET | 945 | 46.67 |
03:02 ET | 1112 | 46.815 |
03:03 ET | 300 | 46.84 |
03:05 ET | 1540 | 46.82 |
03:07 ET | 1141 | 46.85 |
03:09 ET | 641 | 46.835 |
03:12 ET | 600 | 46.845 |
03:14 ET | 2078 | 46.76 |
03:16 ET | 2225 | 46.795 |
03:18 ET | 1814 | 46.82 |
03:20 ET | 733 | 46.82 |
03:21 ET | 1413 | 46.79 |
03:23 ET | 2587 | 46.72 |
03:25 ET | 5708 | 46.855 |
03:27 ET | 810 | 46.8087 |
03:30 ET | 424 | 46.795 |
03:32 ET | 3853 | 47.03 |
03:34 ET | 2485 | 47.105 |
03:36 ET | 8423 | 46.9 |
03:38 ET | 1406 | 46.89 |
03:39 ET | 2366 | 46.79 |
03:41 ET | 2132 | 46.865 |
03:43 ET | 2375 | 46.88 |
03:45 ET | 10387 | 46.78 |
03:48 ET | 3592 | 46.85 |
03:50 ET | 6228 | 46.94 |
03:52 ET | 9986 | 47.005 |
03:54 ET | 6438 | 47.095 |
03:56 ET | 12379 | 46.785 |
03:57 ET | 17489 | 46.79 |
03:59 ET | 19117 | 46.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.7B | -12.4x | --- |
Merus NV | 3.5B | -20.1x | --- |
Immunovant Inc | 4.2B | -15.6x | --- |
Biohaven Ltd | 3.2B | -5.6x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 1,896.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.